Hungarian Biotech Database

News in the Life Sciences Industry
Results 1 - 20 out of 28 displayed.
1 2 »

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)

By: Nasdaq / GlobenewsWire - 22 Mar 2019

Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

By: Nasdaq / GlobenewsWire - 16 Mar 2019

Sanofi successfully prices EUR 2 billion of bond issues

By: Nasdaq / GlobenewsWire - 13 Mar 2019

Sanofi: FDA to undertake priority review of Dupixent® (dupilumab) for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps

By: Nasdaq / GlobenewsWire - 08 Mar 2019

Growing Adoption of AlgaPrime(TM) DHA is Improving Omega-3 Content of Farmed Fish and Accelerating Sustainable Aquaculture

BERGEN, Norway, March 5, 2019 /PRNewswire/ -- Corbion, the global market leader in algae-based food ingredients and BioMar, the leading innovator... Read more ››

By: PR Newswire Association LLC. - 05 Mar 2019

Sanofi : CHMP recommends ZynquistaTM (sotagliflozin) for the treatment of adults with type 1 diabetes

By: Nasdaq / GlobenewsWire - 01 Mar 2019

Sanofi: CHMP recommends approval of Dupixent® (dupilumab) for asthma indication

By: Nasdaq / GlobenewsWire - 01 Mar 2019

Pius S. Hornstein, PhD, Appointed New Country Chair of Sanofi China

SHANGHAI, March 1, 2019 /PRNewswire/ -- Sanofi announced that Pius S. Hornstein, PhD, has been appointed the new General Manager China, China & Emerging Markets Global Business Unit (GBU) of Sanofi and Country Chair of Sanofi China, effective today. Based in Shanghai, he reports directly... Read more ››

By: PR Newswire Association LLC. - 01 Mar 2019

Sanofi: Positive results presented from two Phase 3 trials of Dupixent® (dupilumab) in severe chronic rhinosinusitis with nasal polyps

By: Nasdaq / GlobenewsWire - 25 Feb 2019

Sanofi : Sanofi and Regeneron strongly disagree with verdict upholding three of five Amgen U.S. patent claims relating to PCSK9 antibodies

By: Nasdaq / GlobenewsWire - 25 Feb 2019

Alvogen i Lotus lanseaza primul medicament biosimilar generic al capsulelor tari de Revlimid(TM) in anumite state europene

PINE BROOK, New Jersey, February 14, 2019 /PRNewswire/ --

By: PR Newswire Association LLC. - 14 Feb 2019

Related companies: Alvogen Korea Co., Ltd. | Alvogen | Alvogen Luxembourg | Alvogen CEE Ltd.

Information concerning the total number of voting rights and shares

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Sanofi appoints Ameet Nathwani Chief Digital Officer

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Sanofi delivers 2018 business EPS growth of 5.1% at CER

By: Nasdaq / GlobenewsWire - 07 Feb 2019

Sanofi's Board of Directors notes the resignation of Christian Mulliez and co-opts Christophe Babule as Director

By: Nasdaq / GlobenewsWire - 06 Feb 2019

Sanofi: FDA approves Cablivi® (caplacizumab-yhdp), the first Nanobody®-based medicine, for adults with acquired thrombotic thrombocytopenic purpura (aTTP)

By: Nasdaq / GlobenewsWire - 06 Feb 2019

Sanofi : Isatuximab Phase 3 trial meets primary endpoint of prolonging progression free survival in patients with relapsed/refractory multiple myeloma

By: Nasdaq / GlobenewsWire - 05 Feb 2019

Sanofi: CHMP recommends approval of Praluent® (alirocumab) to reduce cardiovascular risk in people with established atherosclerotic cardiovascular disease

By: Nasdaq / GlobenewsWire - 04 Feb 2019

Sanofi: Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo

By: Nasdaq / GlobenewsWire - 30 Jan 2019

Pfizer actively pushes forward the development and innovation of breast cancer treatment that enhances patients' confidence

SHANGHAI, Jan. 23, 2019 /PRNewswire/ -- Led by the Shanghai Branch of PICC Health Insurance Co., Ltd. (PICC) and the Shanghai MediTrust Health Co., Ltd. as well as supported by Pfizer China, the "Bo'ai Xin'an - Patient Benefit Management Program for breast cancer patients" (hereinafter referred... Read more ››

By: PR Newswire Association LLC. - 23 Jan 2019

1 2 »

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

March 2019
- Vienna: RESI Vienna 2019
- Vienna: BIO-Europe Spring 2019
April 2019
- Zurich: The Pharma Business Development Course

See Events »

Add an Event »

Latest company news

Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin)
22 Mar 2019 (Nasdaq / GlobenewsWire)

Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease
16 Mar 2019 (Nasdaq / GlobenewsWire)

Sanofi successfully prices EUR 2 billion of bond issues
13 Mar 2019 (Nasdaq / GlobenewsWire)

News in the Life Sciences Industry

Looking for companies outside of Hungary?

Partners

Upcoming Life Sciences Events

Latest company news